Interventions: Tumor biopsy was performed twice, and the pathology confirmed condyloma
acuminatum. Immunohistochemistry revealed focal positivity for p16 and Ki-67. Cryotherapy …

No clear guidelines are available for the management of pregnant women with condyloma
acuminata, a human papillomavirus–associated benign neoplasm that develops in the …

Patients with condyloma acuminata (CA) during pregnancy represent a special risk group.
The outcomes of many treatment methods for such cases are not satisfactory. The purpose …

Condyloma acuminatum (CA) is a benign tumor primarily caused by infection with human
papillomavirus (HPV) type-6 or type-11, lesions of which are most frequently found on the …

Objective To investigate pregnancy outcome in patients with condyloma acuminata.
Methods A retrospective cohort study comparing pregnancy outcome of women with and …

Results Patients were treated at a gestational age of 15-38 weeks. During pregnancy follow-
up, 2 patients had recurrences that required repeated treatment before delivery. In each …

Patients with condylomata acuminata of the vulva usually have increased difficulty to
achieve complete response to treatment and also have a higher risk for disease recurrence …

The giant condyloma acuminatum (GCA), also known as Buschke–Löwenstein tumor (BLT),
is a type of human papilloma virus‐associated sexually transmitted infection. Treatment …

Giant condyloma accuminatum (GCA) is known as a Buschke-Lowenstein tumor. GCA has a
morphologic and clinical malignant pattern, but a histologic benign appearance. GCA is …

Bleomycin is an antineoplastic agent, which is used off label for various dermatologic
conditions. There are numerous reports on the use of intralesional bleomycin (ILB) for the …